Tag: global biologics outsourcing market size

  • Comprehensive Biologics Outsourcing Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Biologics Outsourcing Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Biologics Outsourcing Market from 2024 to 2033?

    In recent years, there has been a swift expansion in the market size of biologics outsourcing. The market which is anticipated to rise from $17.74 billion in 2023, is projected to hit $20.33 billion in 2024, boasting a compound annual growth rate (CAGR) of 14.6%. This historic surge can be credited to factors such as mounting research and development expenses, regulatory pressures, the need for specialized skills, and globalization.

    The market size of biologics outsourcing is projected to experience significant growth in the near future. It is anticipated to reach a value of $33.29 billion by 2028, with a compound annual growth rate (CAGR) of 13.1%. Factors such as the growth of emerging markets, personalized medicine, strategic alliances, and biological drug patent expirations contribute to this growth during the forecast period. Foreseen trends include technological advancements, growing complexity in outsourcing, expansion of the biosimilars market, data analytics incorporation, and supply chain resilience.

    Claim Your Free Sample of the Global Biologics Outsourcing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12573&type=smp

    What Key Factors Are Fueling the Growth of the biologics outsourcing Market?

    The increasing incidence of cancer is predicted to fuel the expansion of the biologics outsourcing market in the future. Cancer encompasses a range of diseases where rogue cells multiply uncontrollably, exceed their usual limits, and infiltrate other organs or adjacent body parts. Biologics outsourcing contributes greatly to cancer instances by offering specialist knowledge, facilities, and structure for biologic therapies’ production, development, and clinical distribution, including monoclonal antibodies, immunotherapies, and other targeted biologics employed for diagnosing, treating, and managing various cancer types. For example, the National Center for Biotechnology Information, a US intergovernmental organization, reported 1,958,310 new cancer cases in the United States in January 2023, and anticipates 609,820 cancer deaths in 2023. Additionally, the yearly count of fresh cancer diagnoses is forecasted to grow to 29.5 million and cancer-related deaths to 16.4 million by 2040. Hence, the escalating cancer incidence is stimulating the biologics outsourcing market’s development.

    What Are the Major Segments of the Biologics Outsourcing Market?

    1) By Product Type: Antibodies, Recombinant, Vaccines, Protein, Other Products

    2) By Source: Human, Microbial, Other Source

    3) By Application: Oncology, Cellular and Gene Therapy, Blood And Blood-Related Products Development, Vaccine Development, Stem Cell Research, Other Applications

    4) By End User: Pharmaceutical Industries, Biotechnology Industries, Contract Development And Manufacturing Organization(CDMO)

    What New Trends Are Transforming the Biologics Outsourcing Market?

    One significant trend burgeoning in the biologics outsourcing market is advancements in the biologics sector. To maintain their market position, leading businesses involved in the biologics outsourcing market are employing cutting-edge technologies. For example, in February 2022, a trio comprising Alira Health, a US healthcare company, Abzena, a US contract development and manufacturing organisation (CDMO), and Oncodesign, a biopharmaceutical company based in France, introduced DRIVE-Biologics, a consortium specifically tailored for biologic drug discovery and development ventures. This consortium offers comprehensive solutions, including expert services, ranging from biological discovery to clinical and commercial fabrication. The alliance constructed, incorporating industry leadership in areas like design and developability, proof of concept in preclinical pharmacology and pharmaco-imaging, toxicology, and clinical design to commercial production, aims to enhance information exchange and project deliverables, assisting in minimizing the risks associated with biologics development. Also, the partners will be able to tap into knowledge across all stages of drug discovery and development, including design, preclinical, clinical and CMC (chemistry, manufacturing, and control).

    Order Now for Fast Delivery of Your Biologics Outsourcing Market Report!

    https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

    Which Regions Are Driving Growth in the Biologics Outsourcing Market?

    North America was the largest region in the biologics outsourcing market in 2023. The regions covered in the biologics outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Biologics Outsourcing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biologics outsourcing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Biologics Outsourcing Market Include

    1. Biologics Outsourcing Market Executive Summary

    2. Biologics Outsourcing Market Segments

    3. Biologics Outsourcing Market Size And Template Market Growth Rate

    4. Key Biologics Outsourcing Market Trends

    5. Major Biologics Outsourcing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Biologics Outsourcing Market

    26. Top Biologics Outsourcing Companies

    27. Biologics Outsourcing Market Opportunities And Strategies

    28. Biologics Outsourcing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Automotive Transmission Engineering Services Outsourcing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/automotive-transmission-engineering-services-outsourcing-global-market-report

    IT Outsourcing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/it-outsourcing-global-market-report

    Healthcare RCM Outsourcing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-rcm-outsourcing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Takeaways From The Global Biologics Outsourcing Market Forecast 2024

    Key Takeaways From The Global Biologics Outsourcing Market Forecast 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Biologics Outsourcing Global Market Report 2024, the biologics outsourcing market is expected to show significant growth in the forecast period.

    Understanding the Market Expansion

    • The biologics outsourcing market has experienced significant growth, expanding from $17.74 billion in 2023 to $20.33 billion in 2024.
    • This growth is fueled by various factors including increasing R&D costs, regulatory pressure, demand for specialized expertise, and globalization.

    Projections for Future Growth

    Insights into Forecasted Expansion

    • Projections indicate further growth, with the market expected to reach $33.29 billion in 2028, showcasing a compound annual growth rate (CAGR) of 13.1%.
    • Emerging markets, personalized medicine, strategic alliances, and biological drug patent expirations are key contributors to this anticipated growth.

    Factors Driving Market Growth

    Understanding the Catalysts

    • The surge in cancer cases is a significant driver for the biologics outsourcing market’s growth.
    • Cancer, being a prevalent and complex disease, requires specialized expertise and resources for the development and manufacturing of biologic therapies.

    Influence of Cancer Cases on Market Expansion

    Impact of Rising Cancer Incidences

    • The rising number of cancer cases globally, projected to reach 29.5 million new cases annually by 2040, is a major catalyst for market growth.
    • Biologics outsourcing facilitates the development, manufacturing, and clinical supply of therapies vital for cancer diagnosis, treatment, and management.

    View More On The Biologics Outsourcing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

    Key Players in the Market

    Major Contributors

    • Major companies such as AbbVie Inc., Thermo Fisher Scientific Inc., and Boehringer Ingelheim GmbH play pivotal roles in driving the biologics outsourcing market forward.
    • These companies offer specialized services and infrastructure essential for biologic drug development and manufacturing.

    Transformative Trends and Partnerships

    Driving Market Evolution

    • Developments in biologics and strategic partnerships are reshaping the biologics outsourcing landscape.
    • Companies are adopting new technologies and forming alliances to enhance their capabilities and offerings in the market.

    Notable Industry Developments

    Significant Strategic Moves

    • Partnerships like DRIVE-Biologics consortium aim to provide integrated solutions for biologic drug discovery and development.
    • Acquisitions, such as Asahi Kasei Medical acquiring Bionova Scientific LLC, expand companies’ bioprocess businesses, strengthening their position in the market.

    Market Segmentation

    Understanding the Diversity

    • The biologics outsourcing market is segmented based on product type, source, application, and end-user.
    • Segmentation enables targeted approaches in catering to diverse needs across pharmaceutical and biotechnology industries.

    Regional Insights

    Regional Dynamics

    • North America dominated the biologics outsourcing market in 2023, highlighting the region’s significant contribution to market growth.
    • Understanding regional variations is crucial for identifying market opportunities and strategic positioning.

    Conclusion

    Charting the Path Ahead

    • The biologics outsourcing market continues to expand, driven by factors like technological advancements, strategic alliances, and increasing demand for specialized therapies.
    • Understanding market trends and dynamics is essential for stakeholders to navigate the evolving landscape effectively.

    Request A Sample Of The Global Biologics Outsourcing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12573&type=smp